IDEXX LABORATORIES INC /DE Increase (Decrease) in Operating Capital
IDEXX LABORATORIES INC /DE (IDXX) reported Increase (Decrease) in Operating Capital of $91.64 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingCapital · last filed 2019-02-15
- IDEXX LABORATORIES INC /DE increase (decrease) in operating capital for the quarter ending 2018-12-31 was -$34.68M.
- IDEXX LABORATORIES INC /DE increase (decrease) in operating capital for fiscal 2018 was $91.64M.
| Period end | Increase (Decrease) in Operating Capital 3 month | Increase (Decrease) in Operating Capital 9 month | Increase (Decrease) in Operating Capital 12 month |
|---|---|---|---|
| 2018-12-31 | -$34.68M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $91.64M 10-K · filed 2019-02-15 | |
| 2018-09-30 | $126.32M 10-Q · filed 2018-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |